237 related articles for article (PubMed ID: 24335975)
1. Extensive podocyte loss triggers a rapid parietal epithelial cell response.
Hakroush S; Cebulla A; Schaldecker T; Behr D; Mundel P; Weins A
J Am Soc Nephrol; 2014 May; 25(5):927-38. PubMed ID: 24335975
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss.
Ueno T; Kobayashi N; Nakayama M; Takashima Y; Ohse T; Pastan I; Pippin JW; Shankland SJ; Uesugi N; Matsusaka T; Nagata M
Kidney Int; 2013 Jun; 83(6):1065-75. PubMed ID: 23447065
[TBL] [Abstract][Full Text] [Related]
3. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
4. De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.
Ohse T; Vaughan MR; Kopp JB; Krofft RD; Marshall CB; Chang AM; Hudkins KL; Alpers CE; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F702-11. PubMed ID: 20007346
[TBL] [Abstract][Full Text] [Related]
5. OPN deficiency results in severe glomerulosclerosis in uninephrectomized mice.
Schordan S; Grisk O; Schordan E; Miehe B; Rumpel E; Endlich K; Giebel J; Endlich N
Am J Physiol Renal Physiol; 2013 Jun; 304(12):F1458-70. PubMed ID: 23552865
[TBL] [Abstract][Full Text] [Related]
6. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.
Suzuki T; Matsusaka T; Nakayama M; Asano T; Watanabe T; Ichikawa I; Nagata M
Am J Pathol; 2009 May; 174(5):1675-82. PubMed ID: 19359523
[TBL] [Abstract][Full Text] [Related]
7. The parietal epithelial cell: a key player in the pathogenesis of focal segmental glomerulosclerosis in Thy-1.1 transgenic mice.
Smeets B; Te Loeke NA; Dijkman HB; Steenbergen ML; Lensen JF; Begieneman MP; van Kuppevelt TH; Wetzels JF; Steenbergen EJ
J Am Soc Nephrol; 2004 Apr; 15(4):928-39. PubMed ID: 15034095
[TBL] [Abstract][Full Text] [Related]
8. Podocyte and Parietal Epithelial Cell Interactions in Health and Disease.
Al Hussain T; Al Mana H; Hussein MH; Akhtar M
Adv Anat Pathol; 2017 Jan; 24(1):24-34. PubMed ID: 27677082
[TBL] [Abstract][Full Text] [Related]
9. Podocyte injury and its consequences.
Nagata M
Kidney Int; 2016 Jun; 89(6):1221-30. PubMed ID: 27165817
[TBL] [Abstract][Full Text] [Related]
10. [The role of podocyte injury in chronic kidney disease].
Asanuma K
Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
[TBL] [Abstract][Full Text] [Related]
11. Dendrin location in podocytes is associated with disease progression in animal and human glomerulopathy.
Asanuma K; Akiba-Takagi M; Kodama F; Asao R; Nagai Y; Lydia A; Fukuda H; Tanaka E; Shibata T; Takahara H; Hidaka T; Asanuma E; Kominami E; Ueno T; Tomino Y
Am J Nephrol; 2011; 33(6):537-49. PubMed ID: 21606645
[TBL] [Abstract][Full Text] [Related]
12. The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosis.
Sakamoto K; Ueno T; Kobayashi N; Hara S; Takashima Y; Pastan I; Matsusaka T; Nagata M
Am J Physiol Renal Physiol; 2014 Jan; 306(1):F98-F104. PubMed ID: 24154691
[TBL] [Abstract][Full Text] [Related]
13. Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS.
Zhang J; Pippin JW; Krofft RD; Naito S; Liu ZH; Shankland SJ
Am J Physiol Renal Physiol; 2013 Jun; 304(11):F1375-89. PubMed ID: 23486009
[TBL] [Abstract][Full Text] [Related]
14. Endothelial
Luque Y; Lenoir O; Bonnin P; Hardy L; Chipont A; Placier S; Vandermeersch S; Xu-Dubois YC; Robin B; Lazareth H; Souyri M; Guyonnet L; Baudrie V; Camerer E; Rondeau E; Mesnard L; Tharaux PL
J Am Soc Nephrol; 2017 Dec; 28(12):3563-3578. PubMed ID: 28928136
[TBL] [Abstract][Full Text] [Related]
15. Modulation of podocyte phenotype in collapsing glomerulopathies.
Barisoni L; Kopp JB
Microsc Res Tech; 2002 May; 57(4):254-62. PubMed ID: 12012394
[TBL] [Abstract][Full Text] [Related]
16. The development of focal segmental glomerulosclerosis in masugi nephritis is based on progressive podocyte damage.
Shirato I; Hosser H; Kimura K; Sakai T; Tomino Y; Kriz W
Virchows Arch; 1996 Nov; 429(4-5):255-73. PubMed ID: 8972762
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of CD44-positive glomerular parietal epithelial cells reflects podocyte injury in adriamycin nephropathy.
Okamoto T; Sasaki S; Yamazaki T; Sato Y; Ito H; Ariga T
Nephron Exp Nephrol; 2013; 124(3-4):11-8. PubMed ID: 24401840
[TBL] [Abstract][Full Text] [Related]
18. Mesangial Injury and Capillary Ballooning Precede Podocyte Damage in Nephrosclerosis.
Kriz W; Wiech T; Gröne HJ
Am J Pathol; 2022 Dec; 192(12):1670-1682. PubMed ID: 36150506
[TBL] [Abstract][Full Text] [Related]
19. Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant.
Fatima H; Moeller MJ; Smeets B; Yang HC; D'Agati VD; Alpers CE; Fogo AB
Clin J Am Soc Nephrol; 2012 Nov; 7(11):1852-8. PubMed ID: 22917699
[TBL] [Abstract][Full Text] [Related]
20. Signal regulatory protein α protects podocytes through promoting autophagic activity.
Li L; Liu Y; Li S; Yang R; Zeng C; Rong W; Liang H; Zhang M; Zhu X; Kidder K; Liu Y; Liu Z; Zen K
JCI Insight; 2019 Mar; 5(9):. PubMed ID: 30888336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
